Omega Fund Management, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
OF Omega Fund Management, LLC | Institutional Filer | ▼ 43.06% | $163.1M | 10 |
Current Portfolio Holdings
Showing all 10 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | BCAX | Bicara Therapeutics Inc. Common Stock | Healthcare | 2.4M | $47.6M | 29.16% |
| 2 | NUVB | Nuvation Bio Inc. | Healthcare | 8.1M | $34.7M | 21.25% |
| 3 | BBOT | BridgeBio Oncology Therapeutics Inc. | Healthcare | 3.3M | $29.4M | 18.05% |
| 4 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | Healthcare | 1.0M | $20.4M | 12.49% |
| 5 | BBNX | Beta Bionics, Inc. | Healthcare | 1.3M | $13.2M | 8.08% |
| 6 | ENGN | enGene Holdings Inc. | Healthcare | 876K | $6.0M | 3.66% |
| 7 | ALMS | Alumis Inc. Common Stock | Healthcare | 241K | $5.3M | 3.26% |
| 8 | SANA | Sana Biotechnology, Inc. | Healthcare | 844K | $2.4M | 1.49% |
| 9 | IMA | ImageneBio Inc | Healthcare | 455K | $2.3M | 1.40% |
| 10 | REPL | Replimune Group, Inc. | Healthcare | 249K | $1.9M | 1.17% |
Showing 1 to 10 of 10 holdings